The Clinical Referral to Activity Study
Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
2 other identifiers
interventional
54
1 country
1
Brief Summary
The main aim of this effort is to test a physical activity intervention, for adult clinical care patients at risk of developing cardiovascular disease. The intervention includes social-cognitive theory-based sessions, remote coaching, a body worn physical activity tracker (PAT), and is delivered online over one year. The investigators hypothesis that this intervention will be more successful at increasing physical activity (defined as objectively measured step counts and % of individuals meeting the moderate-vigorous physical activity goal) as an active control group who receives a body worn PAT and information on the CDC activity recommendations. The proposed intervention will be aligned with efforts by the US Centers for Disease Control to increase population physical activity levels and the American College of Sports Medicine (ACSM) to increase physical activity prescription in primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedStudy Start
First participant enrolled
March 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2024
CompletedResults Posted
Study results publicly available
November 19, 2025
CompletedNovember 19, 2025
November 1, 2025
2.5 years
January 10, 2021
November 4, 2025
November 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change From Baseline in Meeting the Aerobic Activity Goal at 12 Months
Change between 0 and 12 months for y/n meeting the 150 minute/week moderate-vigorous activity goal based on minutes of activity from accelerometer
12 months versus baseline
Change From Baseline in Step Counts at 12 Months
Objectively measured change in step counts between 0 and 12 months using ActiGraph accelerometer
12 months versus baseline
Secondary Outcomes (15)
Sedentary Behavior Minutes Over All Timepoints for 12 Months
1 week recording; measured at baseline, 6 and 12 months
Moderate-vigorous Activity Minutes Over All Timepoints for 12 Months
1 week recording; measured at baseline, 6 and 12 months
Light Activity Minutes Over All Timepoints for 12 Months
1 week recording; measured at baseline, 6 and 12 months
Step Counts Over All Timepoints for 12 Months
1 week recording; measured at baseline, 6 and 12 months
Patient Experience
measured at 6 and 12 months
- +10 more secondary outcomes
Study Arms (2)
PAT (Physical activity monitor)
ACTIVE COMPARATORParticipants will receive a physical activity tracker and encouragement to increase physical activity.
ActiveGOALSv2
EXPERIMENTALParticipants will receive the ActiveGOALS online program with an integrated activity tracker.
Interventions
13 weekly self-guided sessions on problem solving and goal setting related to increasing physical activity, and weekly remote coaching support. Once a month support materials sent monthly from months 4-12 of intervention.
Participants will receive a physical activity tracker and encouragement to increase activity.
Eligibility Criteria
You may qualify if:
- Age 40-70 years of age
- Low physical activity (PA) levels (\<150 minutes/week)
- At least one of the following common cardiometabolic risk factors:
- high blood pressure:\> 129 mm hg SP or \>89 mm hg DP or medication
- high fasting glucose:\>100 mg/dl or high HbA1c: ≥42 mmols/mol or medication
- overweight/ obesity: BMI ≥25 kg/m2).
- Have access to the internet
- Able to read English at a 6th grade level
- Have primary care provider (PCP) permission to increase physical activity without supervision.
You may not qualify if:
- Have participated in a physical activity intervention program with behavior tracking and goal setting in the past year.
- Told by a physician that they have diabetes (other than previous gestational diabetes) or have received a diagnosis of cardiovascular disease, regardless of when.
- Pregnant or planning a pregnancy in \<12 months
- Non-ambulatory or planning a procedure that will lead to not being ambulatory in \<12 months.
- Women who become pregnant during the study will be required to get an updated referral form from their primary care provider (PCP) stating that they are able to increase their physical activity without supervision .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This was a small pilot study that was not powered to assess secondary outcomes. The ability to assess the primary outcome of number of participants meeting goal was affected by several factors including: higher than expected participants meeting goal at baseline (based on accelerometers) and higher than expected non-completion rates for the accelerometers.
Results Point of Contact
- Title
- Bonny Rockette-Wagner
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Bonny Rockette-Wagner, PhD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Referring doctors and outcome assessors will be blinded to participant assignment while the study is active. After data collection ends, referring physicians will be informed as to each of their patients assignment. Outcome assessors will remain blinded to participant assignment. Investigators will be blinded to assignment as much as possible. However, certain events ( such as an adverse event report) may cause the study PI to become unblinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 10, 2021
First Posted
February 8, 2021
Study Start
March 29, 2022
Primary Completion
September 30, 2024
Study Completion
December 10, 2024
Last Updated
November 19, 2025
Results First Posted
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share